
It is intended to enhance the industrial as well as the research development and advanced manufacturing capabilities of the company (Antibiotice S.A.) by investment into: (i) advanced manufacturing capabilities for sterile products (topical and powder forms). This sub-project spans all project tasks from project design, procurement and contracting for purchasing European best-in-class manufacturing equipment and clean rooms, regulatory authorisations, good manufacturing practice and test-first batch production. (ii) large Research and Development Centre, including purchasing the most advanced technology equipment and platforms, employment of dedicated personnel as well as the first feasibility steps for the development of the next generation of the Company’s portfolio products. (iii) site digitalization and computerization activities at the manufacturing and operations site
InvestEU operation amount | EUR 25 million |
Sector | Manufacture of basical pharmaceutical products |
Subsector | |
Policy window | Research, innovation and digitisation (RIDW) |
Approval by the Investment Committee | 12 October 2023 |
Links and documents
For further details about signed operations under InvestEU, see Access to EU Finance
Romanian pharmaceutical R&D project
Disclaimer: The Commission gives no warranty and makes no representation, whether expressed or implied, that the information is error free. The information is provided without any guarantees, conditions, or warranties as to its accuracy. This portal is made available for information purposes only.
- Reference
- INVEU-ICR-0064-2023
- Project locations
- Romania
- Policy window
- Research, innovation and digitisation (RIDW)
- Eligible areas
- Research, development and innovation
- Implementing partner
- EIB